Press Releases

PTC is committed to serving the interests of all our stakeholders.
Pam & Kelsey
Living with PKU, United States

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.

Feb 25, 2014
PTC THERAPEUTICS EXPANDS INTERNATIONAL COMMERCIAL TEAM
  SOUTH PLAINFIELD, NJ – FEBRUARY 25, 2014 – PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointment of Guido Schopen, M.D. to General Manager and Head of Medical Affairs for Europe. Dr. Schopen will be responsible for European commercial operations, reporting to Mark Rothera, Chief
Read More
Feb 20, 2014
PTC Therapeutics to Present at Upcoming Investor Conferences
PTC Therapeutics to Present at Upcoming Investor Conferences SOUTH PLAINFIELD, NJ – February 20, 2014 –PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that they will participate in two upcoming investor conferences: - Management will participate in a panel entitled "DMD Back in the Spotlight,
Read More
Feb 12, 2014
PTC THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK
PTC THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK SOUTH PLAINFIELD, NJ - February 12, 2014 - PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the pricing of an underwritten public offering of 4,489,796 million shares of common stock at a public offering price of $24.50 per
Read More
Jan 24, 2014
PTC THERAPEUTICS EXPANDS MANAGEMENT TEAM
SOUTH PLAINFIELD, NJ – January 24, 2013 – PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced an expansion of its senior management team with the appointment of Robert J. Spiegel M.D., FACP to Chief Medical Officer and Murad Husain to Vice President, Global Regulatory Affairs.
Read More